Fresh analysis suggests that individuals who stop using blockbuster weight-loss injections like Mounjaro or Wegovy may regain reduced body mass far faster than those who stop conventional lifestyle programs.
Published data in a major health publication points out that while obese people frequently drop a large proportion of their total mass while using the jabs, the mass returns at an estimated rate of 0.8 kg per month after stopping.
"Users buying such drugs must be informed of the danger of fast rebound weight gain when the medication concludes," stated expert Dr. Susan Jebb.
That rate of recovery suggests a reversion to pre-treatment mass in about one and a half years.
Analyzing Therapies
The study, which looked at 37 of trials involving thousands of participants, contrasted the results of the injectable medications with conventional dieting.
Researchers point out that individuals who shed pounds through lifestyle changes alone usually have a more gradual creep back—perhaps 0.1 kg a month—after stopping.
Understanding the Fast Regain
Doctors suggest the mode of action of the injections explains the accelerated rebound.
These medications imitate a body's own chemical called glucagon-like peptide-1, which helps regulate feelings of fullness.
"Sustained high doses of GLP-1 levels several times higher than normal may cause the system to produce less of its endogenous hormone, and could reduce responsiveness to its effects," noted Dr. Adam Collins, a dietetics expert.
"Withdrawal of this GLP-1 'fix' leads to appetite is no longer kept in check, making binge eating much more probable."
An Ongoing Issue?
Health authorities recommend the injections for individuals with obesity-related medical conditions, accompanied by prescribed diet and exercise modifications.
Many experts contend that, given the significant potential of weight regain, the treatment is often ongoing.
This opinion is echoed by drug manufacturers, who state that the results "emphasize the long-term character of excess weight," akin to managing conditions like hypertension.
User Testimonies
Users who have stopped the jabs report a powerful return of hunger.
"I experienced something activating and I was suddenly starving," recalled an individual.
This challenge is compounded if users have not adopted lasting lifestyle or habit changes during treatment.
Significant Interest
Survey data indicate that millions of adults in the UK have tried these injections in the past year, with desire remaining high.
- Use is greater among women than men.
- The 40s and 50s demographic shows the highest level of interest.
- A large proportion obtain the drugs through private healthcare rather than public health services.
In conclusion, researchers caution that while these medications are potent tools for shedding pounds, they are not a permanent fix and long-term success hinges on integrated behavioural changes.